摘要 |
The present invention provides a compound which is represented by the following structure:
which inhibits, regulates and/or modulates kinase receptors, particularly c-Met, KDR, c-Kit, flt-3 and flt-4. This compound is therefore suitable for the treatment of diseases or disorders associated with uncontrolled, abnormal and/or unwanted cellular activities. |
申请人 |
EXELIXIS, INC. |
发明人 |
BANNEN, LYNNE CANNE;CHAN, DIVA SZE-MING;CHEN, JEFF;DALRYMPLE, LISA ESTHER;FORSYTH, TIMOTHY PATRICK;HUYNH, TAI PHAT;JAMMALAMADAKA, VASU;KHOURY, RICHARD GEORGE;LEAHY, JAMES WILLIAM;MAC, MORRISON B.;MANN, GRACE;MANN, LARRY W.;NUSS, JOHN M.;PARKS, JASON JEVIOUS;TAKEUCHI, CRAIG STACY;WANG, YONG;XU, WEI |